Silvia Ingala
Overview
Explore the profile of Silvia Ingala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cacciaglia R, Falcon C, Benavides G, Brugulat-Serrat A, Aloma M, Calvet M, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14415.
PMID: 39898436
Introduction: Identifying the link between early Alzheimer's disease (AD) pathological changes and neurodegeneration in asymptomatic individuals may lead to the discovery of preventive strategies. We assessed longitudinal brain atrophy and...
2.
Oomens J, van Gils V, Vos S, Freeze W, Maserejian N, Curiale G, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2455571.
PMID: 39841474
Importance: Baseline cerebral microbleeds (CMBs) and APOE ε4 allele copy number are important risk factors for amyloid-related imaging abnormalities in patients with Alzheimer disease (AD) receiving therapies to lower amyloid-β...
3.
Lorenzini L, Maranzano A, Ingala S, Collij L, Tranfa M, Blennow K, et al.
Neurology
. 2024 Sep;
103(7):e209801.
PMID: 39288341
Background And Objectives: Vascular risk factors (VRFs) and cerebral small vessel disease (cSVD) are common in patients with Alzheimer disease (AD). It remains unclear whether this coexistence reflects shared risk...
4.
Lorenzini L, Collij L, Tesi N, Vilor-Tejedor N, Ingala S, Blennow K, et al.
Alzheimers Dement
. 2024 Jul;
20(9):6146-6160.
PMID: 39073684
Introduction: Unraveling how Alzheimer's disease (AD) genetic risk is related to neuropathological heterogeneity, and whether this occurs through specific biological pathways, is a key step toward precision medicine. Methods: We...
5.
Tranfa M, Lorenzini L, Collij L, Garcia D, Ingala S, Pontillo G, et al.
Ann Clin Transl Neurol
. 2024 May;
11(6):1541-1556.
PMID: 38757392
Objective: Alzheimer's disease (AD) and cerebral small vessel disease (cSVD), the two most common causes of dementia, are characterized by white matter (WM) alterations diverging from the physiological changes occurring...
6.
Mehdipour Ghazi M, Selnes P, Timon-Reina S, Tecelao S, Ingala S, Bjornerud A, et al.
Front Aging Neurosci
. 2024 Mar;
16:1345417.
PMID: 38469163
Introduction: Efforts to develop cost-effective approaches for detecting amyloid pathology in Alzheimer's disease (AD) have gained significant momentum with a focus on biomarker classification. Recent research has explored non-invasive and...
7.
Johansen J, Offersen C, Carlsen J, Ingala S, Hansen A, Nielsen M, et al.
Diagnostics (Basel)
. 2024 Jan;
14(1).
PMID: 38201378
DWI/FLAIR mismatch assessment for ischemic stroke patients shows promising results in determining if patients are eligible for recombinant tissue-type plasminogen activator (r-tPA) treatment. However, the mismatch criteria suffer from two...
8.
Sudre C, Van Wijnen K, Dubost F, Adams H, Atkinson D, Barkhof F, et al.
Med Image Anal
. 2023 Nov;
91:103029.
PMID: 37988921
Imaging markers of cerebral small vessel disease provide valuable information on brain health, but their manual assessment is time-consuming and hampered by substantial intra- and interrater variability. Automated rating may...
9.
Padrela B, Lorenzini L, Collij L, Garcia D, Coomans E, Ingala S, et al.
J Cereb Blood Flow Metab
. 2023 May;
43(10):1726-1736.
PMID: 37231665
Aging-related cognitive decline can be accelerated by a combination of genetic factors, cardiovascular and cerebrovascular dysfunction, and amyloid-β burden. Whereas cerebral blood flow (CBF) has been studied as a potential...
10.
Lorenzini L, Ingala S, Collij L, Wottschel V, Haller S, Blennow K, et al.
Brain Commun
. 2023 May;
5(3):fcad088.
PMID: 37151225
Amyloid-β accumulation starts in highly connected brain regions and is associated with functional connectivity alterations in the early stages of Alzheimer's disease. This regional vulnerability is related to the high...